Swapnroop Drugs & Pharmaceuticals is a Ravulizumab API manufacturer, supplier, and exporter in India, offering Ravulizumab biological drug substance for biopharmaceutical research, analytical development, formulation development, and authorized pharmaceutical requirements.
Ravulizumab is a humanized monoclonal antibody designed to target complement protein C5. As a complex biological molecule, its quality evaluation requires specialized analytical, biological activity, protein purity, and stability testing.
We focus on controlled sourcing, consistent product quality, appropriate biological material handling, batch documentation, and technical support according to customer requirements.
We supply Ravulizumab API and biological drug substance to biopharmaceutical companies, pharmaceutical research organizations, contract research organizations, analytical laboratories, formulation development companies, and authorized international buyers.
Our Ravulizumab API supply services support:
Ravulizumab API is supplied with quality parameters evaluated according to applicable biological specifications, analytical methods, and customer requirements.
Typical Quality Parameters Include:
Appearance: As per approved specification
Identification: Complies with specification
Protein Identity: As per validated analytical method
Protein Concentration: As per specification
Biological Activity: As per approved specification
Potency: As per validated biological assay
Protein Purity: As per validated analytical method
Monomer Content: As per specification
High Molecular Weight Species: Within specified limits
Aggregates: Within specified limits
Charge Variants: As per specification
Related Proteins: Within specified limits
pH: As per approved specification
Residual Host Cell Proteins: Within specified limits, as applicable
Residual Host Cell DNA: Within specified limits, as applicable
Protein A Residue: Within specified limits, as applicable
Bioburden: Within specified limits
Bacterial Endotoxins: Within specified limits
Sterility: As applicable
Actual specifications may vary depending on product form, manufacturing process, intended use, biological activity requirements, analytical methods, regulatory requirements, and customer-approved specifications.
Ravulizumab API is used in the biopharmaceutical sector as a monoclonal antibody biological drug substance and terminal complement inhibitor.
Ravulizumab specifically targets complement protein C5 and inhibits terminal complement activation. It is associated with authorized biological products developed for complement-mediated disorders.
Ravulizumab-related pharmaceutical and biopharmaceutical applications include research and development associated with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, generalized myasthenia gravis, and other authorized complement-mediated therapeutic areas.
The biological drug substance is intended for use by licensed biopharmaceutical manufacturers, pharmaceutical research organizations, contract research organizations, analytical laboratories, and authorized institutions.
Swapnroop Drugs & Pharmaceuticals offers reliable Ravulizumab API sourcing and supply solutions for domestic and international biopharmaceutical requirements.
Our Key Advantages:
We support the export of Ravulizumab API and biological drug substance from India to biopharmaceutical companies, research organizations, analytical laboratories, distributors, and authorized international buyers.
Export documentation, product information, storage requirements, and logistics coordination can be provided based on destination-country requirements, customer specifications, intended use, and applicable regulatory procedures.
We serve pharmaceutical and biopharmaceutical buyers across Asia, Africa, the Middle East, Latin America, and other international markets.
Looking for a reliable Ravulizumab API manufacturer in India, Ravulizumab API supplier in India, Ravulizumab biological drug substance supplier, or monoclonal antibody API exporter from India?
Contact Swapnroop Drugs & Pharmaceuticals for Ravulizumab API requirements, technical documentation, COA, SDS, pricing, packaging details, storage requirements, and export inquiries.
Company: Swapnroop Drugs & Pharmaceuticals
Product: Ravulizumab API
CAS Number: 1803171-55-2
Supply Type: Biological API / Monoclonal Antibody Drug Substance / Recombinant Protein
Country of Origin: India
Email: enquiry@sdp.org.in